Physician-Supervised Peptide Program
Peptide Weight Management Program
Medical oversight, labs, and individualized planning — not a product on a shelf.
A physician-supervised weight management track at EBO2 Therapy and Wellness. Candidacy, monitoring, and program design are handled through consultation and labs — peptides are considered only when the supervising physician determines they fit your health profile.
Quick answer
A physician-supervised weight management track at EBO2 Therapy and Wellness. Candidacy, monitoring, and program design are handled through consultation and labs — peptides are considered only when the supervising physician determines they fit your health profile. Medical oversight, labs, and individualized planning — not a product on a shelf.
Program Overview
A supervised program, not an off-the-shelf product
The Peptide Weight Management Program at EBO2 Therapy and Wellness is a supervised clinical service, not an over-the-counter offering. Every program begins with an in-person or virtual consultation where the supervising physician reviews your goals, medical history, current medications, prior labs, and lifestyle inputs before any peptide is considered.
Weight management is a long-arc conversation. The program is structured around measurable inputs — labs, weight and body-composition trends, sleep, nutrition patterns, activity, and how you feel — so any decision about starting, adjusting, pausing, or discontinuing a peptide is grounded in your data, not a template.
This page describes how the program is built. It does not promise a specific amount of weight loss, a timeline, or a specific medication. All decisions belong to the supervising physician after your labs and history are reviewed.
Who It's Considered For
- Adults with clear weight and metabolic goals who want physician oversight rather than a self-directed regimen
- Patients who prefer a lab-guided plan and structured follow-up
- Concierge clients pairing supervised weight support with other wellness tracks
- Individuals who understand that peptides are one adjunct, not a substitute for nutrition, movement, and sleep
Medical Oversight
Physician-directed from consultation onward
A supervising physician at EBO2 Therapy and Wellness leads every step of the program: intake, labs, program design, follow-up, dose adjustments, and safety monitoring. If a GLP-1 or other advanced peptide is added to the plan, it is because the physician has reviewed your labs and determined that consideration is appropriate — and any component of the plan can be adjusted or discontinued at any time based on how you respond.
Options a Physician May Consider
Peptides studied inside this category
Depending on your consultation and labs, the physician may consider one of the following categories as part of a broader lifestyle-supported plan. These are options the physician may consider — not a menu you order from.
Semaglutide
A GLP-1 receptor agonist studied for appetite regulation and metabolic support. Consideration, dosing, and monitoring are entirely at physician discretion after labs.
Tirzepatide
A dual GIP/GLP-1 receptor agonist researched for appetite and metabolic pathways. Whether it is appropriate — and at what cadence — is a physician decision after screening.
Advanced GLP-1 options
Newer GLP-1-class options that the physician may consider based on your health profile, tolerance history, and clinical goals.
Listing here is educational only. Availability of any specific peptide, and whether it is appropriate for you, is determined by the supervising physician after consultation and labs. No outcome is promised, and no FDA approval is claimed for any wellness protocol.
How the Program Starts
Consult → labs → individualized plan
Step 1
Consultation
Private intake with the concierge team followed by physician review — goals, medical history, current medications, prior labs, and lifestyle inputs.
Step 2
Baseline labs
Ordered before any peptide is considered. Results establish a baseline the physician uses to design and monitor the plan.
Step 3
Individualized plan
The physician determines whether a peptide is appropriate, and if so, which category, cadence, and monitoring rhythm. Lifestyle inputs are part of the plan, not an afterthought.
Step 4
Ongoing follow-up
Regular check-ins, labs on the physician's cadence, and adjustments — up, down, pause, or discontinue — based on how you respond.
Program length: Program duration is individualized. Some clients follow a defined multi-month arc; others fold supervised weight support into a longer-term wellness plan. Length, cadence, and any transition are directed by the supervising physician after review of your response and labs.
Safety & Oversight
Non-negotiables of the program
- Baseline and interval labs are required — the plan does not proceed on assumption.
- The physician retains sole authority over which peptide (if any), what cadence, and when to pause or discontinue.
- Pregnancy, breastfeeding, active cancer, personal or family history of certain endocrine conditions, and specific medications may exclude or modify options.
- Any new symptom is reviewed with the clinical team before the next dose.
- The program is one adjunct inside a broader plan — it is not a substitute for medical care from your primary or specialty providers.
Candidacy, monitoring cadence, and overall program structure are discussed at consultation. This page does not discuss insurance coverage, compounding, or brand-specific product sourcing — those conversations belong in-clinic between you and the supervising physician.
What Programs Cost
Discussed at consultation
Program pricing is discussed at consultation and depends on the physician's plan, labs cadence, and how long the program runs. We do not publish per-vial or per-dose pricing — the model is a supervised program, not a product purchase.
Related Peptide Programs
Explore other physician-supervised tracks
Cellular Longevity Program
Physician-directed longevity-focused peptides considered inside a lab-guided plan.
Learn more →
Recovery Program
Soft-tissue and post-effort recovery peptides considered under supervision.
Learn more →
Energy & Vitality Program
Physician-guided energy and vitality peptides reviewed at consultation.
Learn more →
FAQ
Common Questions About the Peptide Weight Management Program
Who is a candidate for the Peptide Weight Management Program?
How does the program start?
How long does the program run?
How is safety monitored?
What does the program cost?
Is this a weight-loss guarantee?
Begin Your Journey
Ask about the Peptide Weight Management Program
Programs start with a private consultation, labs, and a physician-directed plan — not a checkout.
Available at our clinics
Peptide Therapy in California & Florida
Explore peptide therapy at each EBO2 Therapy and Wellness location, or dig into a side-by-side comparison and the clinical guide.
Medically reviewed by Daniel Moghadam, MD.
Page updated: July 2026
This page is maintained by EBO2 Therapy and Wellness to answer common questions about Peptide Weight Management Program. Content is educational and is not a substitute for consultation, screening, and provider guidance. See the full Medical Disclaimer at the end of this page.
How candidacy for Peptide Weight Management Program is evaluated
- Medical history, current medications, and prior labs are reviewed at consultation.
- Baseline labs are ordered before any peptide program is started.
- Pregnancy, breastfeeding, active cancer, and certain conditions may exclude or modify options.
- Selection of any specific peptide, dose, and cadence is entirely at physician discretion.
- Peptide programs are wellness-focused and are not a substitute for medical care; results vary.
Screening, history, and provider guidance determine whether any protocol is appropriate for a given individual. Results vary.
Where this information comes from
FDA approvals for GLP-1 products such as WEGOVY are specific to a particular product, route, dose, and indication and do NOT transfer to compounded semaglutide, unapproved GLP-1 formulations, or investigational peptide stacks (e.g. BPC-157, MOTS-c, TB-500). FDA has flagged dosing errors with compounded semaglutide and safety risks with several bulk peptide substances. Programs at EBO2 remain physician-supervised.
- WEGOVY (semaglutide) — FDA prescribing label
DailyMed (U.S. National Library of Medicine)
Current FDA-approved prescribing information for WEGOVY, defining approved indication, dosing, route, and safety information. Approval is product/route/indication-specific.
- FDA alerts providers, compounders, and patients to dosing errors with compounded semaglutide
U.S. Food & Drug Administration
FDA safety alert on dosing errors associated with compounded semaglutide. Regulatory/safety context only; does not endorse compounded products.
- FDA intends to take action against non-FDA-approved GLP-1 drugs
U.S. Food & Drug Administration
FDA statement on planned enforcement against non-FDA-approved GLP-1 products. Regulatory context; not a recommendation for any specific program.
- FDA — Certain Bulk Drug Substances Used to Compound Drug Products May Present Significant Safety Risks
U.S. Food & Drug Administration
FDA safety-risk framing for bulk drug substances used in compounding — the category that covers BPC-157, MOTS-c, TB-500, and related investigational peptides. Risk/regulatory context only.
- FDA — Unapproved Drugs enforcement policy overview
U.S. Food & Drug Administration
FDA overview of how the agency treats drugs that lack FDA approval, providing regulatory context for compounded and unapproved products.
References describe general evidence, safety, or regulatory context. They do not establish an individual benefit for any specific person, and they do not validate EBO2's proprietary clinic protocols.